Trials / Active Not Recruiting
Active Not RecruitingNCT06494241
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP; To evaluate the treatment pattern in metastatic NSCLC patients after QIP.
Detailed description
The primary objective of this study is to assess the implementation of standardized diagnosis and treatment practice in oncology departments of Small/Middle tier cities and County hospitals, after standardized education and implementation of lung cancer clinical practice guidelines for oncology physicians.
Conditions
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Neoplasms by Site
- Neoplasms
- Lung Diseases
- Respiratory Tract Diseases
- Carcinoma, Bronchogenic
- Bronchial Neoplasms
Timeline
- Start date
- 2024-11-22
- Primary completion
- 2027-11-28
- Completion
- 2027-11-28
- First posted
- 2024-07-10
- Last updated
- 2026-01-30
Locations
46 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06494241. Inclusion in this directory is not an endorsement.